Cargando…
Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study
INTRODUCTION: Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2. Although most patients with COVID-19 develop asymptomatic or mild disease, some patients develop severe disease. The effectiveness of various therapeutic agents, including antiviral drugs, ster...
Autores principales: | Shionoya, Yu, Taniguchi, Toshibumi, Kasai, Hajime, Sakuma, Noriko, Imai, Shun, Shikano, Kohei, Takayanagi, Shin, Yahaba, Misuzu, Nakada, Taka-aki, Igari, Hidetoshi, Sakao, Seiichiro, Suzuki, Takuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412353/ https://www.ncbi.nlm.nih.gov/pubmed/34473766 http://dx.doi.org/10.1371/journal.pone.0256977 |
Ejemplares similares
-
Clinical Outcomes of Sotrovimab Treatment in 10 High-Risk Patients with Mild COVID-19: A Case Series
por: Takeda, Kenichiro, et al.
Publicado: (2022) -
Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
por: Tawara, Junsuke, et al.
Publicado: (2021) -
COVID-19 infection control education for medical students undergoing clinical clerkship: a mixed-method approach
por: Kasai, Hajime, et al.
Publicado: (2022) -
Tolerability of prone positioning in non‐intubated patients with hypoxaemia due to COVID‐19‐related pneumonia
por: Shikano, Kohei, et al.
Publicado: (2022) -
A Comparison of Clinical Presentations in Coronavirus Disease 2019 Caused by Different Omicron Variants in Japan: A Retrospective Study
por: Hirama, Ryutaro, et al.
Publicado: (2023)